title: [Susceptibility of non-typhi Salmonella spp. at the Galdakao Hospital (1992-1998)].
abstract: Non-typhi Salmonella spp. are a common cause of gastroenteritis. In patients with a greater risk of bacteremia (those with immunosuppression, cardiovascular abnormalities, prostheses, those older than 50, especially those with atherosclerosis, and neonates) the need for antibiotic treatment may be affected by the presence of resistance. We retrospectively studied the evolution of antibiotic resistance of 917 strains isolated from feces, during the period between January 1992 and May 1998. Resistances of 32.1% to ampicillin, 14.6% to amoxicillin- clavulanic acid, 14.8% to chloramphenicol, 3.5% to trimethoprim-sulfamethoxazole and 1.8% to gentamicin were found. All the strains were susceptible to cefotaxime and ciprofloxacin. There was a distinct increase in the ampicillin resistance (12.9% in 1992 to 52.5% in 1998), amoxicillin-clavulanic acid (8.3% in 1992 to 23% in 1998), chloramphenicol (8.3% in 1994 to 23% in 1998) and trimethoprim-sulfamethoxazole (0% in 1992 to 6.6% in 1998). The typhimurium serotype showed higher resistance levels than the enteritidis serotype. Ciprofloxacin and trimethoprim-sulfamethoxazole (in children), used as first-choice antibiotics in patients with intestinal infections caused by non-typhi Salmonella spp., show excellent activity in our area.
authors.affiliation: Servicio de Microbiología, Hospital de Galdakao, Bo de Labeaga s/n, 48960 Galdakao (Vizcaya).
authors.forename: M J
authors.initials: MJ
authors.lastname: López De Goicoechea
authors.forename: M J
authors.initials: MJ
authors.lastname: Echeverría
authors.forename: P
authors.initials: P
authors.lastname: Berdonces
authors.forename: R
authors.initials: R
authors.lastname: Ayarza
mesh_terms: D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D019779:Salmonella enterica / Q000187:drug effects*; D013030:Spain